AbbVie, Inc. (ABBV)

202.98 -2.14 (-1.04%) USD  |  NYSE  |  Apr 22, 11:49
More

AbbVie Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Amgen, Inc. Upgrade
Biogen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade